Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Revenue (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Revenue for 16 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue fell 2.26% to $7.8 million in Q4 2025 year-over-year; TTM through Nov 2025 was $31.6 million, a 1.31% decrease, with the full-year FY2025 number at $31.6 million, down 1.31% from a year prior.
  • Revenue was $7.8 million for Q4 2025 at Cryo Cell International, roughly flat from $7.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $8.1 million in Q3 2024 to a low of $6.9 million in Q1 2021.
  • A 5-year average of $7.7 million and a median of $7.8 million in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: dropped 9.97% in 2021, then rose 7.8% in 2023.
  • Cryo Cell International's Revenue stood at $7.3 million in 2021, then grew by 6.13% to $7.8 million in 2022, then rose by 1.45% to $7.9 million in 2023, then increased by 1.87% to $8.0 million in 2024, then fell by 2.26% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Revenue are $7.8 million (Q4 2025), $7.8 million (Q3 2025), and $7.9 million (Q2 2025).